Bone Scan Clinic PET Scan 
AuntMinnie
JULY 1, 2024
In small studies, F-18 PSMA-1007 PET/CT has shown promise as a more accurate approach based on its ability to reveal prostate-specific membrane antigen (PSMA) on the surface of cancer cells. In this phase II clinical trial, the researchers sought to evaluate the approach further.
AuntMinnie
JULY 8, 2024
Gayton oversees clinical operations at Precirix and serves as the company's chief development officer. Twenty of the 26 scans from patients with active tumors were NeoB-positive, six NeoB-negative. Both groups would undergo standard of care imaging, or CT and bone scan, or FDG PET/CT, or FES PET/CT.
Expert insights. Personalized for you.
105 
Let's personalize your content